Assyro AI

FDA Orange Book · active-ingredient family

Miglitol

Miglitol is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:GLYSET · NDA 020682

1

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
GLYSETRLD×3PFIZERNDA 020682Dec 18, 1996

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
MIGLITOL×3ORIENT PHARMAANDA 203965Feb 24, 2015

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Miglitol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.